Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left

Jeroen J Bax1, Jerry Braun, Soeresh T Somer

  • 1Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. jbax@knoware.nl

Circulation
|September 15, 2004
PubMed

Insights

Combined coronary artery bypass grafting and restrictive annuloplasty effectively treat ischemic cardiomyopathy, significantly reducing mitral regurgitation and improving left ventricular remodeling. This procedure offers excellent long-term outcomes for patients with severe mitral regurgitation.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Cardiovascular Imaging

Background:

  • Limited data exists on combined coronary artery bypass grafting (CABG) and restrictive annuloplasty for ischemic cardiomyopathy.
  • The impact of this combined approach on left ventricular (LV) reverse remodeling remains largely unknown.

Purpose of the Study:

  • To evaluate the efficacy of combined CABG and restrictive annuloplasty in patients with ischemic cardiomyopathy and severe mitral regurgitation.
  • To assess the impact of this combined surgical strategy on mitral regurgitation, left atrial dimension, and LV reverse remodeling.

Main Methods:

  • 51 patients with ischemic LV dysfunction and severe mitral regurgitation underwent CABG and restrictive annuloplasty with mitral annulus downsizing.
  • Serial echocardiographic studies assessed mitral regurgitation, transmitral gradient, leaflet coaptation, and LV/left atrial dimensions.
  • Clinical follow-up evaluated New York Heart Association (NYHA) class, survival, and adverse events at 2 years.

Main Results:

  • The combined procedure resulted in minimal residual mitral regurgitation (grade 1+) in all patients at 2-year follow-up.
  • Significant improvements were observed in LV end-systolic and end-diastolic dimensions, indicating reverse LV remodeling.
  • Left atrial dimensions also significantly decreased, and NYHA class improved from 3.4 to 1.3.

Conclusions:

  • Combined restrictive annuloplasty and CABG yield excellent clinical and echocardiographic results.
  • The procedure effectively eliminates/minimizes mitral regurgitation and promotes significant reverse LV remodeling.
  • This surgical approach demonstrates favorable long-term outcomes, including high survival rates and improved functional class.
Abstract

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...